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TwoDogmas of Biology
Leonore Fleming
The problem with reductionism in biology is not the reduction, but the implicit attitude
of determinism that usually accompanies it. Methodological reductionism is supported
by deterministic beliefs, but making such a connection is problematic when it is based on
an idea of determinism as fixed predictability. Conflating determinism with predictability
gives rise to inaccurate models that overlook the dynamic complexity of our world, as well
as ignore our epistemic limitations when we try to model it. Furthermore, the assumption
of a strictly deterministic framework is unnecessarily hindering to biology. By removing
the dogma of determinism, biological methods, including reductive methods, can be ex-
panded to include stochastic models and probabilistic interpretations. Thus, the dogma of
reductionism can be saved once its ties with determinism are severed. In this paper, I ana-
lyze two problems that have faced molecular biology for the last 50 years—protein folding
and cancer. Both cases demonstrate the long influence of reductionism and determinism
onmolecular biology, as well as how abandoning determinism has opened the door to more
probabilistic and unconstrained reductive methods in biology.
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1 Introduction
Echoing W. V. O. Quine (1951), modern biology has been conditioned in large part by two
dogmas: (1) One is reductionism—broadly understood as a belief that biological entities and
processes correspond to some simpler, lower level—where “the reductive method par excellence
is the ‘dissection of biological systems into their constituent parts’ (Van Regenmortel 2004,
1016)” (Kaiser 2015, 74); (2) The other is determinism—broadly understood as the necessity
of fixed future states—where causal determinism is the idea that “given a specified way things
are at a time t, the way things go thereafter is fixed as a matter of natural law” (Hoefer 2016).
Both dogmas play a large role in motivating and guiding biological research, although their
presence is often only implied rather than stated outright. For example, in an editorial for
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the journal Infection and Immunity, Fang and Casadevall claim, “Few scientists will voluntarily
characterize their work as reductionistic. Yet, reductionism is at the philosophical heart of the
molecular biology revolution” (2011, 1401). They go on to call molecular biology “a triumph of
reductionism” claiming that reductionism “is implicit in much of molecular and cellular biology”
(Fang and Casadevall 2011, 1402). And the same can be said about determinism, although such
discussion is much more rare.
Continuing to parallel Quine, we can say that reductionism is “intimately connected” with
determinism (cf. 1951, 38). In an article discussing systems biology, Mazzocchi says, “In mod-
ern science reductionism is usually combined with a linear and simplistic idea of causality, where
the focus is restricted to the role of a single or few essential causes or factors (occurring at the
fundamental physical level), and with determinism” (2012, 414, emphasis added). He continues
by explaining that determinism “is the idea whereby any phenomenon in nature is completely
determined by pre-existing causes to which it is bound by a relationship of necessity, and that
only one possible future exists” (2012, 414). The main point of this paper is to argue that this
“intimate connection” between reductionism and determinism is restrictive and problematic for
biological research. Nevertheless, and in contrast to Quine’s original argument, my conclusion
is not that both dogmas are completely ill-founded; rather, I claim we can sacrifice one to save
the other. Reductionism is often criticized for being incomplete or misleading, which perhaps
explains Fang and Casadevall’s statement that few scientists would openly call their research
reductionistic, and while I do typically tend to agree with such criticisms, my conclusion in this
paper is that the main problem with reductionism in biology is not the reductive method per se.
Instead, the problem is the implicit attitude of determinism that usually accompanies it. Thus,
I argue that the second dogma is what is really hindering to biological research and needs to be
abandoned. Doing so will remove a critical constraint on biology and in turn reform the first
dogma—reductionism—such that it can incorporate more probabilistic methods, and produce
more adequate biological explanations.
My argument in this paper is threefold: (a) reductionism and determinism motivate much
research in biology, especially molecular biology; (b) there is an intimate connection between
reductionism and determinism (i.e., there is a natural association between the reductive method
and a deterministic framework); and (c) this connection is problematic because it is based on
a misunderstanding of determinism and deterministic systems. To support these points, the
bulk of this paper is spent analyzing two problems that have faced molecular biology for the
last 50 years—protein folding and cancer. Both cases demonstrate the combined influence of
the two dogmas on molecular biology, the subsequent problems, and how biological practice
has or has not changed in response. Before delving into such biological detail, however, I will
provide some additional explanation regarding points (b) and (c) of my argument in the next
two subsections, respectively.
1.1 Reductionism and Determinism
Methodological reductionism is intimately connected with strict determinism. The “idea that
complex systems or phenomena can be understood by the analysis of their simpler components”
(Fang and Casadevall 2011, 1401), is supported by the idea that lower level entities behave in
simple, linear, and completely predictable ways. This reductive method of decomposition “as-
sumes that there are but a small number of such functions that together result in the behavior
we are studying, and that they are minimally interactive. We start with the assumption that
interaction can be handled additively or perhaps linearly” (Bechtel and Richardson 2010, 23).
Further, a key belief of methodological reductionism is that it “counts as reductionistic not only
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to decompose a biological object or system into parts, but also to study the parts in isolation”
(Kaiser 2015, 225). The parts of a system are understood as “intrinsically determined” and as
such can be studied on their own, isolated from their original context (Bechtel and Richardson
2010, 26; Kaiser 2015, 225). The idea that any interactions between parts are predictable, sim-
ple, and sequential relies on the assumption of a strictly deterministic framework (Kaiser 2015,
233). As summed up by Soto and Sonnenschein, “those that assume a reductionist stance hope
that eventually a neat, linear causal chain will be identified” (2006, 372). In other words, reduc-
tionism and determinism seem to go hand in hand fairly easily.
1.2 Determinism and Predictability
A common misconception is that determinism is the same thing as fixed predictability (Hoefer
2016; Werndl 2016). The two are so easily conflated that even Laplace and Popper have made
the mistake (Hoefer 2016). While it is easy to confuse the notions of determinism and pre-
dictability, the important distinction is that the former is an ontological claim, while the latter
is an epistemological claim. Determinism is the general idea that the state of a system (whether
real or a model) at one time fixes the past and future states of that system (Butterfield 2005).
Predictability, on the other hand, is the ability to compute or forecast the future based on the
accurate measurement of initial states and conditions. Since human measurement will never be
perfectly accurate, it should come as no surprise that deterministic systems can be unpredictable
in a variety of ways (Werndl 2016), which reveals the problem with defining determinism as
complete predictability.
As recent advances in mathematics have shown (the most famous being chaos theory), de-
terministic systems can display random and irregular behavior (Werndl 2009, 203). Probably
the most well known example of a chaotic system is the weather. Imagine a model based on
the amount of daily precipitation in an area. Whether or not this precipitation system actually
follows deterministic laws, the fact that there is inaccuracy in initial conditions, even the tini-
est amount, means that this system is unpredictable, or as Werndl explains it more specifically,
the system is “asymptotically unpredictable” because the slight inaccuracies in initial conditions
“eventually over time spreads out more than a specific diameter representing the prediction ac-
curacy of interest” (2016, 671). Accurate predictability is not possible for this system, even if
it is ultimately deterministic in nature. The ontology of the system ultimately doesn’t matter,
because what does matter is the type of predictability or unpredictability in our system, and if
we are aware of our epistemic limitations, then we should accommodate that in our modeling
and our science.
Indeterministic systems involve the likelihood of many possible future states, and thus, what
can be predicted from such systems are probability distributions or sets of possible outcomes.
Indeterministic processes can be modeled stochastically as processes that evolve over time ac-
cording to probabilistic laws. And while it might go against our intuition,Werndl demonstrates
that “deterministic and indeterministic models can be observationally equivalent” (2016, 677).
By comparing a deterministic daily precipitation model with an indeterministic coin-flipping
model, Werndl shows that the two models give the same predictions, relative to an observation
function, whichmeans that deterministic models and stochastic models are not, in fact, mutually
exclusive (2009; 2013; 2015; 2016). The moral of the story is that the assumption of determin-
ism in biological research can be doubly problematic. First of all, it’s likely built on a mistaken
definition of fixed predictability, rather than the recognition that determinism and predictability
are different concepts, and that deterministic processes can be unpredictable in many different
ways. Second, this typical mistaken definition incorrectly categorizes deterministic processes
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and stochastic processes as mutually exclusive, which is unnecessarily hindering to biological
research and methodology. However, if we abandon the dogma of determinism, our biological
methods (such as reductionism) can be more open-minded to including stochastic models and
probabilistic methodologies, in spite of any underlying biases or “hope that eventually a neat,
linear causal chain will be identified.”
2 Protein Folding and Disordered Proteins
Over the last 50 years, the prevailing view in biochemistry has been “sequence determines struc-
ture determines function,” or The Central Dogma of Genomics, as it has been called (Petsko
2000). The basic idea is that a one-dimensional polypeptide chain (string of amino acids) codes
for a unique, folded, three-dimensional functional structure (a protein). Since Christian B. An-
finsen’s groundbreaking research on protein folding in the 1960s (which led to him sharing
the Nobel Prize in Chemistry in 1972), one huge question remains unanswered: How can a
sequence of amino acids code for one specific 3D structure? For over 50 years biochemistry
has been trying to explain how proteins that are denatured in the lab can refold into their na-
tive structure at a speed too fast to be the result of tedious searching or trial and error, given
the astronomically large number of possible conformations. The breakthrough was expected
to come from computer programs and algorithms built with information about physical forces
and other molecular factors thought to influence proteins (e.g., hydrogen bonds, van der Waals
interactions). In fact, “The early days saw hopes of finding simple sequence patterns—say of
hydrophobic, polar, charged, and aromatic amino acids—that would predict protein structures
and stabilities. That has not materialized” (Dill and MacCallum 2012, 1043). Such factors are
clearly relevant to protein structure, however, it appears that the mechanism of protein folding
is much more complicated than first thought. The now seemingly impossible task of predicting
protein structure from amino acid sequence is known as the “protein-folding problem.” And al-
though the “early days” were optimistic in assuming that computer algorithms developed within
a deterministic and reductionist framework would solve the problem, the context for addressing
protein folding has changed.
There are a number of worldwide competitions designed with the goal of finding the best
computer algorithms to predict protein structure from amino acid sequence. The most famous
is “Critical Assessment of protein Structure Prediction,” or CASP, which began in 1994 and is
held every two years. Its 12th competition was scheduled to start in May 2016, and since the
competition is always blind, the unpublished structures and results will be revealed in December
2016, when the 12th competition is set to complete. As Dill and MacCallum summarize it, “A
grand challenge has been to develop a computer algorithm that can predict a protein’s 3D native
structure from its amino acid sequence” (2012, 1043). But there is a common theme of disap-
pointment and astonishment at how far we are from attaining this goal, especially considering
the amount of time, money and importance placed on the pursuit. Additionally, with each new
CASP competition there are more known protein structures to draw upon as public databanks
grow rapidly. For example, as of August 18th 2016, the Protein Data Bank (Berman et al. 2000)
had 113,095 proteins listed in their current holdings with 98,510 structures containing a struc-
ture factor file. Yet, according to Dill and MacCallum, since CASP6, “overall progress has
slowed” (2012, 1044). Despite our increasing knowledge of protein structures, when it comes
to predicting them based on amino acid sequences, “only modest gains were made over the last
decade for certain classes of prediction targets” (Khoury et al. 2014, 1815).
The most recent competition, CASP11, was perhaps more encouraging than typical, due
in large part to new methods of evolutionary coupling (Monastyrskyy et al. 2015). One of the
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most successful groups, CONSIP2, led by David Jones of UCL, used evolutionary coupling and
neural network architectures. Evolutionary coupling is based on the idea that “pairs of amino
acids that interact with each other tend to ‘co-evolve’; that is, if one amino acid changes, then
the second amino acid also changes in order to accommodate it” (Ovchinnikov et al. 2015, 2).
Identifying these pairs and their changes by creating a contact map adds helpful constraints
for predicting how proteins can possibly fold. Neural network architectures are “trained” using
historical data and examples, and can automatically “learn” certain dependencies or constraints
based only on those examples ( Jones et al. 2014). What is obvious is that CONSIP2, and all
the top contenders at CASP11, are stochastic, based on evolving probabilities (Kryshtafovych
et al. 2015). The “grand challenge” might be presented deterministically, and past practice may
be deterministic, but it is now clear that the best solutions are modeled stochastically, and still
far away from making successful, fixed predictions. As the best model of CASP11, CONSIP2
achieved only 27% accuracy on de novo target proteins, yet such a result “indicates a break-
through” (Monastyrskyy et al. 2015, 131).
Nonetheless, onemight argue that the deterministic “sequence-structure-function” approach
to protein folding still holds in-principle, if not yet in-practice. Such a claim runs into prob-
lems though if “wild-type” proteins from cell cultures are considered (Gershenson and Gierasch
2011). Unlike the protein folding that occurs in a highly diluted lab context, naturally-occurring
proteins are affected by their cellular environment, including shape changes like those resulting
from post-translational modifications (PTMs), which are not considered in the CASP struc-
tural predictions (Kryshtafovych et al. 2014). As discussed in Section 1.1, reductionism, when
pursued under the bias of a deterministic framework, emphasizes decomposition and isolation
of parts, assuming that those parts are “intrinsically determined.” What protein folding research
has shown us, however, is that our best predictive models currently include dynamic informa-
tion such as how amino acid pairs interact. Additionally, isolating techniques are beginning
to be supplemented with “wild-type” protein experiments to further assist in understanding
the age-old problem of protein folding. Even if these trends could be ignored, the determinis-
tic framework of “sequence-structure-function” is threatened by a larger problem—intrinsically
disordered proteins and intrinsically disordered protein regions.
2.1 Intrinsically Disordered Proteins
According to the conventional wisdom, a normal functioning protein has a predictable, folded
structure. Proteins that lack regular form are considered malfunctioning, and cause neurodegen-
eration and diseases like Parkinson’s and Alzheimer’s, as well as contribute to various cancers, of
which it has been found that 79% of proteins that are associated with cancer contain malfunc-
tioning (i.e., disordered) regions 30 residues or longer (Liu and Huang 2014). Therefore, the
common understanding is that proteins that do not fit the “sequence-structure-function” mold
are defective. Yet, starting about ten years ago, evidence began to accumulate of proteins and
protein regions that, despite lacking a predictable structure, are extremely functional.
Initially called “unstructured,” the literature used at least 35 other terms to describe these
dynamic yet functional proteins before settling on “disordered” (Uversky 2013). Intrinsically
Disordered Proteins (IDPs) and Intrinsically Disordered Protein Regions (IDPRs or IDRs) do
not display a regular form, however, that does not mean they lack structure; quite the contrary,
they have the potential to occupy a range of unfolded, partially folded, and fully folded, func-
tional structures. And because IDPs can shift between these structures, they are often called
“non-foldable” based on their lack of any well-defined “normal” structure. Although protein
disorder sounds harmful, IDPs and IDPRs are present in all healthy organisms, and it is cur-
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rently estimated that around 15%–45% of all eukaryotic proteins, and around 10%–35% of all
prokaryotic proteins, contain disordered regions at least 30 residues in length (Dill andMacCal-
lum 2012; Tompa 2012; Xue et al. 2012). Looking only at mammals, it is estimated that around
75% of mammalian signal proteins contain disordered regions at least 30 residues in length, and
about half of the total proteins in mammals are estimated to have long disordered regions, with
about 25% of those proteins thought to be fully disordered (Xue and Uversky 2016). Addition-
ally, there is a growing number of examples illustrating how protein disorder is not only useful
but also necessary for normal cellular functioning (Shoemaker et al. 2000; Pansca and Tompa
2012; Uversky 2013; Liu and Huang 2014). Clearly, IDPs/IDPRs are more the rule than the
exception.
Examples of IDPs/IDPRs thus far have shown an astounding number of differently disor-
dered states at all structural levels (primary, secondary, tertiary, quaternary), and well as an abil-
ity to switch between them: “Currently available data suggest that intrinsic disorder possesses
multiple flavors, can have multiple faces, and can affect different levels of protein structural orga-
nization, where whole proteins or various protein regions can be disordered to a different degree”
(Xue and Uversky 2016, 136). Vladimir Uversky claims that “one can even assume that every
disordered protein (or at least every family of disordered proteins) is disordered in its own way”
(2013, 701). This poses a large problem for the researcher following the deterministic (fixed pre-
dictability) approach, since one sequence seems to lead to an unpredictable range of structures
and functions. If the idea of determinism is abandoned, however, then the variety of structures
that are exhibited by an IDP/IDPR can be modeled and predicted stochastically. Furthermore,
reductive methods that focus on amino acid sequence are then useful for predictive purposes, as
long as they include the understanding that ‘protein structure’ is dynamic, and protein folding
(or non-folding) is a probabilistic process. In other words, by removing the dogma of determin-
ism. The 50-year deterministically motivated protein-folding problem ceases to exist because,
as Dill and MacCallum say, “we believe it is no longer useful to frame the question this way.
Protein folding is now a whole field of research—a large, growing, and diverse enterprise …
bigger than any individual research question” (2012, 1045).
3 Cancer Evolution and Chromosomal Instability
Reflecting back on the last 40 years of cancer research, Robert Weinberg, a leading cancer re-
searcher and biology professor at MIT, has “witnessed wild fluctuations from times where end-
less inexplicable phenomenology reigned supreme to periods of reductionist triumphalism and,
in recent years, to amove back to confronting the endless complexity of this disease” (2014, 267).
The reductionist (and determinist) illusion was strongest for him in 1982, when it appeared that
certain cancers could be attributed to a single genetic mutation. The prediction was that a small
number of mutations could explain all cancerous growths; an expectation that nicely confirms
Soto and Sonnenschein’s claim that “those that assume a reductionist stance hope that eventu-
ally a neat, linear causal chain will be identified” (2006, 372). However, the optimism of this
theory was fleeting, and “From the point of view of the reductionist hoping that a small num-
ber of molecular events might explain cancer, things went downhill from there for the next 30
years” (Weinberg 2014, 269). Weinberg continues, explaining that “two simple notions—that
small numbers of genes would suffice to transform cancer cells, and that all mammalian cells
would follow the same set of genetic rules during the course of neoplastic transformation—were
undermined” (2014, 269). With more and more failed predictions, the variation and complex-
ity of cancer at the molecular level became increasingly apparent to the point that “each tumor
seemed to represent a unique experiment of nature, acquiring a unique set of mutant genes and
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in an unpredictable chronological order” (Weinberg 2014, 269). In other words, each mutated
tumor appeared mutated in its own way.
Since the year 2000, when the era of big data was already gaining speed, reductive analyses
were primary, consumed by the notion that genome sequencing would uncover hidden answers.
The trend continues today, with an emphasis on sequencing and big data, yet, as Weinberg
laments, we still lack the general ability to predict cancer progression (cf. 2014, 270). As an ex-
ample, The Cancer Genome Atlas (TCGA) used large-scale genome sequencing and genome
analysis techniques to “systematically explore the entire spectrum of genomic changes involved
in more than 20 types of human cancer” (National Institutes of Health 2016). Started in 2006,
TCGA officially completed in 2014 having discovered nearly 10 million cancer-related muta-
tions after genetically profiling around 10,000 tumors. When the almost 400 million dollar
project completed, Heidi Ledford reported in Nature News that “Although a few ‘drivers’ stood
out as likely contributors to the development of cancer, most of the mutations formed a bewil-
dering hodgepodge of genetic oddities, with little commonality between tumours” (2015, 128).
Despite the very many efforts to discover those genetic mutations that “drive” oncogenesis, it
appears that such a deterministic and reductive search is not only inconclusive, but also wrong-
headed.
Data now show that populations of cancer cells taken from clinical settings are incredibly
heterogeneous at multiple levels, much more than was expected, which directly challenges the
reductionist-determinist method of decomposition and isolation discussed in Section 1.1 (Hep-
pner 1984; Torres et al. 2007; Park et al. 2010; Navin et al. 2011; Baca et al. 2013). More than
ten years ago, at the International Cancer Genomics ConsortiumMeeting, a point of consensus
among the members was the rather implicitly deterministic view that the “Heterogeneity of a
selected tumour type should be as small as possible to allow for the identification of relevant
mutations. Therefore, prioritization of the initial set of tumour types must consider the genetic
heterogeneity of a given tumour type” (2007, 5). In other words, mutations should be investi-
gated based on the assumption that they are intrinsically determined to cause cancer, and thus
can be investigated outside their original context. And although such minimization of varia-
tion can make initial lab work simpler, the problem, of course, is when such research is applied
to “real world” cell populations in clinical situations, where it is found that it consistently fails
(Stepanenko and Kavsan 2012; Watson 2013). A reductive, deterministically motivated investi-
gation assumes that “eventually a neat, linear causal chain will be identified,” which is why cancer
research is still searching for specific driver mutations that are inextricably linked with cancer
development. Such a discovery would provide a way to accurately predict (and remove) with
certainty the presence of cancer (assuming the system is deterministic and the measurements
completely accurate). As such methods have repeatedly proven disappointing, an alternative is
viewing cancer as an evolutionary process, with selection acting on heterogeneous populations
at multiple levels. This more closely resembles real world cell populations as observed in clinical
settings, confirming Weinberg’s claim that the recent trend in cancer research is “a move back
to confronting the endless complexity of this disease” (2014, 267).
3.1 Chromosomal Instability
Much cancer research today focuses on the evolutionary dynamics of cancer growth at different
levels of biological hierarchy: “Some investigators focus on the particular features of the cells
themselves; some focus on features of whole populations of such cells; some focus on hierarchical
or spatial relations between cells; some focus on interactions between cancer cells and their
microenvironment” (Lean and Plutynski 2016, 45). Christopher Lean and Anya Plutynski
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Figure 1: The two phases of cancer evolution. The punctuated phase represents a group of
cells with high Chromosomal Instability (CIN), which results in rapid, genome-level changes
that are unique to each individual cell. There is competition among these unstable cells, and
the survivor (the circle) expands clonally during the stepwise phase. Genome-level changes
from the first phase are stabilized, and minor, lower-level genetic changes evolve gradually (pie
slices). Since research on cancer evolution is almost entirely focused on the second phase, it is
good to remember that those mutations recorded from the second phase, are the result of the
very random and erratic process from phase one. Figure from Horne et al. (2015), reproduced
with permission.
argue that all of these factors likely affect cancer development, and “The key is to see this as
a multilevel selection process, with selection operating at distinct levels simultaneously” (2016,
53). This includes individual selection, such as among cells, as well as group selection, like at
the level of cell populations or lineages, or at the level of cell colonies. It is this last example,
at the level of cell populations or cell colonies, i.e., the genome level, that Henry Heng and
colleagues found what they claim is a unifying feature of all cancers—Chromosomal Instability
(CIN) (2013). CIN is measured by the cell-to-cell variability of karyotypes (the number and
structure of chromosomes) within a specific cell population. Karyotype variation can be due to
the loss of entire chromosomes or fractions of chromosomes, or due to the increase or decrease
of nonclonal chromosomal aberrations (NCCAs), which are seemingly random variations in
karyotypes that alter the entire karyotype landscape. Such karyotype alterations, in turn, cause
the individual genes within those chromosomes to change unpredictably.
Single-cell or single-nucleus genome sequencing has shown that from the perspective of
the genome, cancer appears to evolve in two very distinct phases—punctuated and stepwise
(Heng et al. 2006; Heng et al. 2013; Horne and Heng 2014; Wang et al. 2014; Horne et
al. 2015). As illustrated in Figure 1, the first stage is “punctuated” because of rapid and unstable
genome-level changes (NCCAs) that are unique to each individual cell. During this first phase,
individual cells are competing with each other. The survivor(s) propagate during the second,
stepwise stage of cancer evolution, when minor lower-level genetic changes evolve gradually.
The erratic genome-level changes from the first stage are now stable and have been duplicated
uniformly via clonal reproduction. In other words, the first stage is characterized by dynamic
nonclonal chromosomal aberrations (NCCAs), while the second stage consists of established
clonal chromosome aberrations (CCAs).
It is during the second phase of cancer evolution that the majority of cancer research has
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focused. However—and this is the important point—the mutations in the second phase that are
used to distinguish and classify a cancer cell population, are unpredictable, and the result of the
random, genome-level changes from the chaotic first evolutionary phase. Thus, the mutations
studied in the second phase that are investigated as potential “drivers” of cancer development, are
the result of a highly stochastic and noisy process of individual selection among a lot of precari-
ous, precancerous cells. There is nothing deterministic, linear or predictable about the way these
mutations come about. In fact, it has been shown that cell populations in the punctuated phase
are so unstable and unpredictable that they cannot be cloned, even in a short amount of time.
According to Batoul Abdallah and colleagues, “Each cell sampled exhibited a unique karyotype
within a short time-span, making it clear that these karyotypes are not clonable” (2013, 3643).
And whereas the population in the stepwise phase exhibited uniform proliferation among cells,
the unstable cell populations from phase one were quite variable in cell cycle times and overall
population growth (Abdallah et al. 2013). For example, the doubling times in unstable cell
populations were unique, leading to very unequal growth distributions as there were often a few
extreme outliers. In other words, cancer research needs to shed any remaining assumptions of
determinism or strict predictability, because the process is very random and irregular.
Clearly, shifting the focus of cancer research from the second evolutionary phase to the first
evolutionary phase is not a complete or good solution, but neither is continuing to pursue a de-
terministic, reductive search for specific cancer-causing “driver” mutations in the second phase.
If cancer is understood evolutionarily, then it must also be understood probabilistically. The
composition of a tumor cell population is the result of a dynamic, stochastic process; hence the
reason Weinberg would claim that “each tumor seemed to represent a unique experiment of na-
ture” (2014, 269). When determinism, and the related goal of finding specific cancer-causing
mutations, is abandoned, cancer research is less constrained andmore open-minded. Reduction-
ism, without the burden of determinism, can still search for cancer-causing mutations in cell
populations; however, the relevant context for such a search is broadened to include real world
cell populations, guided by an updated understanding that cancer development is best under-
stood as a stochastic, multi-level, evolutionary process among heterogeneous populations. Ac-
cording to Lean and Plutynski, “What started as a minority view has now become an active area
of research, drawing upon mathematical modeling, computer simulation, experimental evolu-
tion in model systems, and even the generation of phylogenies, or branching evolution in cancer
progression …” (2016, 40). Though perhaps not yet the dominant framework for investigating
cancer, abandoning the dogma of determinism gives rise to a less restricted, interdisciplinary,
enlightened view of cancer as a multi-level evolutionary process.
4 Biology without Determinism
Deborah Gordon, whose current research projects include studying ant behavior in space (cf.
Countryman et al. 2015), said “the limits to what we know about ants are set as much by how
we frame the problem as by the number of person-hours spent getting the answer” (2010, 13).
As a graduate student in the early 1980s, Gordon worked under the fairly deterministic and
reductive paradigm set by E.O.Wilson that ants are genetically programmed to fill certain roles
and carry out specific tasks optimal for the functioning of the entire colony (cf. Gordon 2010,
5-6). However, Gordon’s research, then and now, challenges the algorithmic perception of a
functioning ant colony, replacing it with the view that underneath the fairly predictable and
efficient colony system is a noisy bunch of erratic ants that “bump into each other as they travel
through an unpredictable world …” (2010, 146). According to Gordon, if we observe ants in
great detail, we notice that “There is stochasticity, randomness and noise, both in how ants react
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and in what they are reacting to” (Gordon 2010, 142–143). Thus, predicting the behavior of
an individual ant with any real accuracy is rather impossible since “an ant’s reactions are not
deterministic” (Gordon 2010, 143).
Much stochasticity and unpredictability has also been documented at the molecular level
(as a few examples, in cellular decisions, Balázsi et al. 2011; cell death, Stevens et al. 2013; and
gene expression and RNA splicing, Marinov et al. 2014). However, a sense of determinism
still lingers near to the genetic code, as if the amino acid sequence can only be understood as
a hard-and-fast instruction manual of predictable future states. Yet, as Weinberg points out,
molecular research has shown that our reductive attempts to gather and hoard large amounts
of data “overwhelm our abilities of interpretation” (2014, 270) to the point that “The coupling
between observational data and biological insight is frayed if not broken” (2014, 271); send-
ing us down the wrong path, time and time again. The problem is not with methodological
reductionism, or with amassing huge quantities of data at the molecular level, but rather, as
I argue, doing so within a strictly deterministic framework, assuming fixed predictability and
misunderstanding the difference between determinism and predictability. As reductive meth-
ods easily cohere with expectations of simple linearity, this mistaken view of determinism ad-
versely affects the pursuit of reductionism as well. Luckily, with the removal of determinism
and the false promise of complete predictability, a critical constraint is lifted from biological
and reductionistic methodologies. In the case of the protein folding problem, the removal of
determinism welcomed in dynamic predictive models of protein structure; the recognition that
naturally occurring proteins behave much differently than proteins isolated in the lab; and the
acknowledgement that disordered proteins are fairly common, and that different “flavors” of
disorder can be modeled stochastically. Similarly in the case of cancer research, the removal of
determinism opened the door to investigating real world, heterogeneous cell populations; and
the stochastic modeling of cancer populations as irregular, dynamic, multi-level, evolutionary
processes ushered in a new wave of understanding cancer, which is much more complex than
the search for specific genetic mutations. Falling is the framework of understanding proteins in
terms of “sequence-structure-function.” Weakening is the framework of understanding cancer
as the result of “specific cancer-causing driver mutations.”
I have argued that there are two dogmas in biology that influence biological research and
methodology—reductionism and determinism. Two examples frommolecular biology—protein
folding and cancer—have helped me demonstrate that the dogma of determinism is problem-
atic and hindering to biological research, and thus should be abandoned. Furthermore, because
“those that assume a reductionist stance hope that eventually a neat, linear causal chain will be
identified,” reductionistic methods are particularly vulnerable to deterministic ways of thinking
(Soto and Sonnenschein 2006, 372). However, if the assumption of determinism is removed,
reductionistic methodology is less restricted and better able to incorporate irregular, dynamic
behaviors. While I am advocating for the abandonment of determinism, especially as it influ-
ences reductive methods in biology, it is good to remember Bechtel and Richardson’s claim
about the strategies of decomposition and localization: “We may be led to erroneous explana-
tions, but it may be the only way to begin the task of explaining and understanding complex
systems. The failure of decomposition is often more enlightening than is its success…” (Bechtel
and Richardson 2010, 23–24).
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